BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for VistaGen Therapeutics, Inc. (VTGN)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for VistaGen Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
4:28 pm
Purchase		 2024-12-31 13G VistaGen Therapeutics, Inc.
VTGN		 BIOTECHNOLOGY VALUE FUND L P 3,084,324
9.970%		 307,079increase
(+11.06%)		 Filing
2023-10-16
4:34 pm
Purchase		 2023-10-04 13G VistaGen Therapeutics, Inc.
VTGN		 BIOTECHNOLOGY VALUE FUND L P 2,777,245
9.990%		 2,777,245increase
(New Position)		 Filing